Designing a virtual reality-based rehabilitation therapy for Parkinson disease
Objective: The study aims to determine design considerations for a virtual reality-based therapy targeting motor disabilities of Parkinson disease (PD) patients. Background: PD has the…Cognitive Safety and Stability in DBS for Parkinson’s Disease: Evidence for the Inclusion of Patients with Baseline Mild Cognitive Impairment.
Objective: Investigate the cognitive safety of Deep Brain Stimulation (DBS) in PD patients with baseline pre-operative diagnosis of Mild Cognitive Impairment (MCI) Background: DBS is…Hepatic Biomarker Profile Across Parkinson’s Disease Severity Stages in a Peruvian Cohort
Objective: To determine changes in serum hepatic biomarker concentrations according to Parkinson's disease (PD) severity in Peruvian adults. Background: PD is a progressive neurodegenerative disorder.…The Effect of Depression on the Cognitive Phenotype in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia.
Objective: To investigate the impact of depression on cognitive functioning in a group of older adults without dementia. Background: Parkinson’s disease (PD) is a neurodegenerative…Bridging the Gap: Physical Activity and Rehabilitation Patterns in Patients with Parkinsonism
Objective: Characterize physical activity participation and rehabilitation referral patterns among patients with parkinsonism. Background: Parkinson's disease (PD) and other parkinsonisms are frequently associated with significant…Electrocardiographic Indicators of Autonomic Dysfunction in Parkinson’s Disease: A Scoping Review and Meta-analysis
Objective: To systematically map and quantitatively synthesize evidence on ECG-derived markers associated with autonomic dysfunction in PD and evaluate their ability to differentiate patients from…Skin Tau Quantification as a Potential Degeneration Biomarker in Parkinson’s Disease
Objective: This cross-sectional observational study aims to quantify total skin Tau levels in Parkinson’s disease (PD) patients and explore their association with clinical symptoms. Background:…Unnecessary Ablative Surgery in an Untreated Parkinson’s Disease Patient: Marked Clinical Improvement After Initiation of Dopaminergic Therapy
Objective: To report a case of Parkinson’s disease (PD) in which two ablative procedures were performed without prior dopaminergic therapy, followed by significant clinical improvement…Risk factors for dysautonomic fluctuations in Mexican PwP
Objective: To identify risk factors for non-motor dysautonomic fluctuations in people living with Parkinson’s disease (PwP). Background: Advanced Parkinson’s disease (PD) is characterized by motor…Levodopa Initiation in Phase 3 Trials of Tavapadon, a Selective D1/D5 Agonist for Early Parkinson’s Disease
Objective: To evaluate motor improvements in adults with early Parkinson’s disease (PD) who initiated levodopa (LD) during phase 3 trials of tavapadon. Background: Tavapadon, an…
- « Previous Page
- 1
- …
- 57
- 58
- 59
- 60
- 61
- …
- 553
- Next Page »